FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...

FibroBiologics is planning a prospective, multicenter, open-label clinical trial evaluating the safety, tolerability, and efficacy of CYWC628 in treating refractory diabetic foot ulcers with up to 12 ...

BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 28, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced results ...

Dr. Koen Deloose describes his algorithmic approach to treating a patient with chronic limb-threatening ischemia and a nonhealing ulcer, with discussion from Drs. Katherine McMackin and Constantino ...

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved balance sheet through multiple direct offerings; complet ...

A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved ...

Postdoctoral researcher Shivam Shukla from Florida International University develops non-invasive tools that improve early detection of non-healing diabetic wounds.

Researchers at the University of California, Riverside have developed a small, battery-powered oxygen-generating gel designed to heal chronic diabetic foot ulcers, a condition that frequently leads to ...

I have a diabetic nonhealing ulcer on my right heel. I was told that the blood circulation in my foot is not very good, which ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Foot Ulcers pipeline constitutes 20+ key companies continuously working towards developing 25+ ...

Diabetic foot ulcers (DFUs) continue to represent one of the most significant and costly complications related to diabetes mellitus, posing serious challenges to healthcare systems and resulting in ...